Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Oct
22
2019
Vape Lung Disease Chills Cannabis Industry Stark & Stark
Oct
22
2019
Opioid Update: Bellwether Settlement on Eve of Trial Squire Patton Boggs (US) LLP
Oct
22
2019
New York Court Compels Arbitration of Commercial Marijuana Dispute Carlton Fields
Oct
22
2019
USPTO October 2019 Patent Eligibility Guidance Update Includes New Guidance And Examples For Life Sciences Foley & Lardner LLP
Oct
21
2019
Federal Appeals Court Holds Test For Illegal Drugs Is Not An Impermissible Medical Examination, Even If Test May Reveal Lawful Drug Use Jackson Lewis P.C.
Oct
21
2019
PTO Releases New Guidelines on Subject Matter Eligibility
Oct
21
2019
Lawmaker Calls for FDA to Respond to Report on Toxic Metals in Baby Food Keller and Heckman LLP
Oct
21
2019
FDA Warns Consumers to Stop Using THC Vaping Products Amid Ongoing Investigation into Lung Injuries Dinsmore & Shohl LLP
Oct
18
2019
BRAG Biobased Products Blog: October 18, 2019 Bergeson & Campbell, P.C.
Oct
18
2019
USDA Announces Renewal of Substance Exemptions in the National Organic Program Keller and Heckman LLP
Oct
17
2019
Mexico’s Lower House Passes Front-of-Pack Labeling Bill Keller and Heckman LLP
Oct
17
2019
California Tackles Big Pharma’s Anticompetitive ‘Pay for Delay’ Practices That Slow Down Lower-Cost Generic Drug Development MoginRubin
Oct
16
2019
Personalized Cancer Therapy Found Nonobvious Foley & Lardner LLP
Oct
16
2019
Pork Workers Union Sues USDA Over New Swine Slaughter Inspection System Keller and Heckman LLP
Oct
15
2019
Not Another Puff Piece: The Difference Between Puffery and False Advertising ArentFox Schiff LLP
Oct
15
2019
EPA OIG Will Evaluate Implementation of 2009 TSCA PMN Consent Order with DuPont [Chemours] Bergeson & Campbell, P.C.
Oct
15
2019
Federal Circuit Reverses PTAB Finding Tarceva® Method of Treatment Claims Invalid for Lack of Reasonable Expectation of Success Based on over 99.5% Failure Rate among Treatment Candidates Mintz
Oct
15
2019
Federal Circuit Reverses PTAB On Reasonable Expectation Of Success For TARCEVA Patent Foley & Lardner LLP
Oct
15
2019
Suit Over ‘No Preservatives’ Capri Sun Label Tossed Keller and Heckman LLP
Oct
15
2019
FTC Ratchets up Scrutiny on Pharmaceutical Deals McDermott Will & Emery
Oct
11
2019
Text Message Platform Dismissed From TCPA Class Action Because It Was Not the “Maker or Initiator” of Text Message Womble Bond Dickinson (US) LLP
Oct
11
2019
U.S. Immigration and the Growing Marijuana Industry Jackson Lewis P.C.
Oct
11
2019
Overlapping Provisions in Major Healthcare Bills 2019 McDermott Will & Emery
Oct
11
2019
BRAG Biobased Products Blog: October 11, 2019 Bergeson & Campbell, P.C.
Oct
11
2019
OSI v. Apotex – Christmas in October!
Oct
11
2019
Do You Want Fries With That? Mintz
Oct
11
2019
Trade Associations Send Letter to All Members of Congress Urging Action on CBD in Dietary Supplements Keller and Heckman LLP
Oct
11
2019
Cannabis Consumer Class Actions: The Implicit and Indispensable Ascertainability Requirement Carlton Fields
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins